Product Review

Viteyes areas 2 plus omega-3 is based on the findings of the areas 2 study, plus 1,000 mg of omega-3. Completed in 2013, areas 2 was a 5-year follow-up study by the national eye institute (near) of the original areas study. Ares 2 resulted in the neiandapo recommendation to revise the original areas formula to help further slow the progression of and. Viteyes areas 2 plus omega-3 contains vitamin C 500 mg, vitamin E 400 if, zinc 25 mg, copper 2 mg, lutein 10 mg, zeaxanthin 2 mg, and amp; omega-3 1,000 mg. Ares 2 analyzed the areas formula with and amp; without beta-carotene, due to the risk of lung cancer for smokers/former smokers. The areas 2 study also researched adding lutein and zeaxanthin. Ares 2 participants who took lutein and amp; zeaxanthin and no beta-carotene reduced their risk of developing advanced stages of and by 18 percent compared to those in areas 2 who took the original areas with beta-carotene. As a result, ned's areas 2 suggests modifying the areas formula by omitting beta-carotene and adding lutein and zeaxanthin. Zinc levels: in the original areas study, the dose for zinc was high (80 mg) because a previous small trial had found that high-dose zinc was beneficial for and. However, some nutritionists were concerned the dose was too high. The areas 2 study tested zinc at 80 mg and amp; 25 mg. The results showed that when lowering zinc there was "no statistically significant effect on progression to advanced and." (near website 2013. Ares 2 media quondam; areds2 research group. The age-related eye disease study 2 (areds2) controlled randomized clinical trial and quote; jam, published online may 5, 2013). These statements have not been evaluated by the food and amp; drug administration. This product is not intended to diagnose, treat, cure or prevent any disease.